RANI
Rani Therapeutics Holdings Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.32
+0.03 ▲ +2.33%
🌙 3월 13일 7:18 PM ET (한국 3/14 08:18)
$1.30
-0.02 ▼ -1.52%
| Index | - | P/E | - | EPS (ttm) | -0.79 | Insider Own | 25.15% | Shs Outstand | 0.10B | Perf Week | 1.54% |
| Market Cap | 0.16B | Forward P/E | - | EPS next Y | 36.47% | Insider Trans | -11.16% | Shs Float | 0.07B | Perf Month | 2.33% |
| Enterprise Value | 0.17B | PEG | - | EPS next Q | -0.05 | Inst Own | 28.51% | Short Float | 15.8% | Perf Quarter | -15.38% |
| Income | -0.03B | P/S | 133.68 | EPS this Y | 59.52% | Inst Trans | 12.24% | Short Ratio | 8.93 | Perf Half Y | 161.54% |
| Sales | 0.00B | P/B | - | EPS next 5Y | 35.44% | ROA | -105.5% | Short Interest | 11.54M | Perf YTD | -2.22% |
| Book/sh | -0.16 | P/C | 34.57 | EPS past 3/5Y | -35.62% 4.78% | ROE | -1372.59% | 52W High | -65.89% ($3.87) | Perf Year | -9.59% |
| Cash/sh | 0.04 | P/FCF | - | Sales past 3/5Y | -27.67% 0.98% | ROIC | - | 52W Low | 241.09% ($0.39) | Perf 3Y | -78.54% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 25.08% | Gross Margin | 18.33% | Volatility(W/M) | 6.19% 6.3% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 141.01 | Sales Y/Y TTM | - | Oper. Margin | -3418.25% | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.26 | EPS Q/Q | 50.47% | Profit Margin | -2359.58% | RSI (14) | 49.04 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.26 | Sales Q/Q | - | SMA20 | -0.6% ($1.33) | Beta | 0.44 | Target Price | $8 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -0.68% ($1.33) | Rel Volume | 0.61 | Prev Close | $1.29 |
| Employees | 105 | LT Debt/Eq | - | EPS/Sales Surpr. | 21.31% - | SMA200 | 27.26% ($1.04) | Avg Volume(3M) | 1.29M | Price | $1.32 |
| IPO | 2021/7/30 | Option/Short | Yes/Yes | Trades | 1477 | Volume | 790,391 | Change | 2.33% |
뉴스 로딩 중...